Objective: To determine the expressions of multiple genes in the subcutaneous adipose
tissue of HIV-positive, highly active antiretroviral therapy (HAART)-treated patients with and …

Highly active antiretroviral therapy (HAART) has improved the prognosis of human
immunodeficiency virus (HIV)-infected patients but is associated with severe adverse events …

Background The aetiopathogenic bases of HIV-1-/highly active antiretroviral treatment
(HAART)-associated lipodystrophy (HALS) are poorly known, but this syndrome indicates …

In this cross-sectional study, we sought to determine whether gene expression of
macrophage markers and inflammatory chemokines in lipoatrophic subcutaneous …

Objective: Lipodystrophy in HIV-1–infected antiretroviral-treated patients is often associated
with opposite alterations in adipose tissue depots as follows: lipoatrophy of subcutaneous …

Objective To achieve a better understand of the pathophysiology of HIV-related lipoatrophy,
we compared the mRNA expression of adipocytokines in fat samples from patients and …

Objective and design: The present study aims at evaluating the influence of genetic
polymorphisms on antiretroviral therapy (ART)-associated lipodystrophy. We included in the …

HIV-1-infected patients on antiretroviral therapy frequently develop a lipodystrophy
syndrome, characterized by peripheral lipoatrophy and visceral fat redistribution associated …

Objective: To elucidate the pathogenesis of HAART-associated lipodystrophy, by
investigating the effects of antiretroviral drugs on adipocyte differentiation and gene …

Lipodystrophy and metabolic alterations are major complications of antiretroviral therapy in
HIV‐infected patients. In vitro studies using cultured murine and human adipocytes revealed …